Pertussis Vaccination During Pregnancy: Regional Situation and Impact of Implementation on National Immunization Programs in Latin America
Authors:
- Angela GentileAGAngela Gentile
- Vanesa E. CastellanoVanesa E. Castellano
- Rolando Ulloa-GutierrezRolando Ulloa-Gutierrez
- Lourdes DueñasLDLourdes Dueñas
- Juan P. TorresJTJuan P. Torres
- Giannina IzquierdoGIGiannina Izquierdo
- Ana Cristina MariñoAMAna Cristina Mariño
- Mónica Pujadas FerrerMónica Pujadas Ferrer
- Daniel JarovskyDJDaniel Jarovsky
- Theresa J. OchoaTOTheresa J. Ochoa
- Soraya A. Araya YampeySYSoraya A. Araya Yampey
- José L. Díaz OrtegaJOJosé L. Díaz Ortega
- 14 February 2025
- journal article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 44 (2S) , S80-S84
Abstract
Background: Infants face a high risk of morbidity and mortality from pertussis early in life, leading to the adoption of maternal vaccination. This study aimed to review the characteristics of the maternal pertussis vaccination in Latin American (LATAM) countries and evaluate their impact on pertussis absolute mortality and case fatality rate (CFR) in infants under 1 year old. Methods: LATAM countries with maternal tetanus, diphtheria and acellular pertussis (Tdap) vaccination in their National Immunization Programs were included. Data on pertussis incidence, deaths and cases in <1-year-old; characteristics of Tdap vaccination in pregnancy; and third dose of diphtheria, tetanus and pertussis and Tdap coverage rates were collected and analyzed. The impact on absolute mortality and CFR was assessed by comparing the percentage reduction between 4 years before and after (up to 2019) the Tdap introduction for each country. Results: The LATAM countries included were Argentina, Brazil, Chile, Costa Rica, Colombia, El Salvador, Mexico, Panamá, Paraguay, Peru and Uruguay. Post-Tdap introduction, pertussis incidence declined notably, especially from 2020. The beginning of the maternal Tdap strategy varied, occurring between 2012 and 2019, with a common recommendation at 20 weeks gestation. In most countries, absolute mortality and CFR decreased, though variations ranged from −9.9% to 88.9% and −60.6% to 81.2%, respectively. Tdap and third dose of diphtheria, tetanus and pertussis coverage rates declined by 2021, with rates ranging from 37% to 92% and 58% to 95%, respectively. Conclusion: The characteristics of maternal Tdap vaccination varied across LATAM countries. The vaccine implementation into the National Immunization Program has reduced pertussis cases, deaths and CFR in infants <1-year-old in most countries.Keywords
This publication has 18 references indexed in Scilit:
- Epidemiology of pertussis in Costa Rica and the impact of vaccination: A 58-year experience (1961–2018)Vaccine, 2022
- Incidence and mortality of pertussis disease in infants <12 months of age following introduction of pertussis maternal universal mass vaccination in Bogotá, ColombiaVaccine, 2020
- A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussisExpert Review of Vaccines, 2020
- Pertussis in Latin America: Recent epidemiological data presented at the 2017 Global Pertussis Initiative meetingVaccine, 2019
- An update of the global burden of pertussis in children younger than 5 years: a modelling studyThe Lancet Infectious Diseases, 2017
- Maternal Immunization Earlier in Pregnancy Maximizes Antibody Transfer and Expected Infant Seropositivity Against PertussisClinical Infectious Diseases, 2016
- Maternal immunization in Argentina: A storyline from the prospective of a middle income countryVaccine, 2015
- Risk Factors Associated With Infant Deaths From Pertussis: A Case-Control StudyClinical Infectious Diseases, 2015
- Pathology and Pathogenesis of FatalBordetella pertussisInfection in InfantsClinical Infectious Diseases, 2008
- Pertussis of adults and infantsThe Lancet Infectious Diseases, 2002